Antonio Di Rubbo

Mr. Antonio Di Rubbo

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2019 in Journal of Virological Methods
Verified
Journal Article
Closed access
ARAntonio Di Rubbo
Antonio Di Rubbo
LMLeanne McNabb
Leanne McNabb
RKR. Klein
R. Klein
JWJohn White
John White
ACA. Colling
A. Colling
RLR.A. Lunt
R.A. Lunt

26 May 2019 in Viruses
Verified
Journal Article
Open access
PDF file
FLFabian Z. X. Lean
Fabian Z. X. Lean
MNMatthew Neave
Matthew Neave
JWJohn White
John White
JPJean Payne
Jean Payne
TETeresa Eastwood
Teresa Eastwood
JBJohn Bingham
John Bingham
The embryonated chicken egg (ECE) is routinely used for the laboratory isolation and adaptation of Bluetongue virus (BTV) in vitro. However, its utility as an alternate animal model has not been fully explored. In this paper, we evaluated the pathogenesis of BTV in ovo using a pathogenic isolate of South African BTV serotype 3 (BTV-3) derived from the blood of an infected sheep. Endothelio- and neurotropism of BTV-3 were observed by immunohistochemistry of non-structural protein 1 (NS1), NS3, NS3/3a, and viral protein 7 (VP7) antigens. In comparing the pathogenicity of BTV from infectious sheep blood with cell-culture-passaged BTV, including virus propagated through a Culicoides-derived cell line (KC) or ECE, we found virus attenuation in ECE following cell-culture passage. Genomic analysis of the consensus sequences of segments (Seg)-2, -5, -6, -7, -8, -9, and -10 identified several nucleotide and amino-acid mutations among the cell-culture-propagated BTV-3. Deep sequencing analysis revealed changes in BTV-3 genetic diversity in various genome segments, notably a reduction of Seg-7 diversity following passage in cell culture. Using this novel approach to investigate BTV pathogenicity in ovo, our findings support the notion that pathogenic BTV becomes attenuated in cell culture and that this change is associated with virus quasispecies evolution.


21 November 2024 in Viruses
Verified
Journal Article
Open access
PDF file
ARAntonio Di Rubbo
Antonio Di Rubbo
KAKalpana Agnihotri
Kalpana Agnihotri
TBTimothy Bowden
Timothy Bowden
MGMichelle Giles
Michelle Giles
KNKim Maree Newberry
Kim Maree Newberry
JWJohn White
John White
A newly formatted enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to bluetongue virus (BTV) was developed and validated for bovine and ovine sera and plasma. Validation of the new sandwich ELISA (sELISA) was achieved with 949 negative bovine and ovine sera from BTV endemic and non-endemic areas of Australia and 752 BTV positive (field and experimental) sera verified by VNT and/or PCR. The test diagnostic sensitivity (DSe) and diagnostic specificity (DSp) were 99.70% and 99.20%, respectively, for bovine sera, and 97.80% and 99.50%, respectively, for ovine sera. Comparable diagnostic performances were noted for the sELISA compared to four competition ELISAs. While the sensitivity of the sELISA remained unaffected by BTV-15 positive sera, the cELISAs were not as sensitive. BTV-15 is endemic to Australia, and early warning depends on sensitive diagnoses of all serotypes: endemic or incurring. The sELISA failed to discriminate against epizootic hemorrhagic disease virus (EHDV) antibodies, the most serologically related orbivirus to BTV. The ACDP cELISA and the IDEXX kit showed cross-reactivity with some EHDV serotypes, with the least cross-reactive being the VMRD and the IDVet kits. Cross-reactivities, however, were also detected in sera raised experimentally from 10 isolates of the 21 known non-BTV orbiviruses. In this case, the sELISA was the least affected, followed equally by the VMRD and IDVet kits, and the IDEXX kit and the ACDP cELISA were the least discriminatory. In addition to exclusivity assessment of the ELISAs, an inclusivity assessment was made for all ELISAs using well characterized reference sera positive for antibodies to all serotypes BTV-1 to BTV-24.

Verified
Journal Article
Open access
PDF file
APAbbey Potter
Abbey Potter
CBCraig A Brockway
Craig A Brockway
KMKimberly L. Miller
Kimberly L. Miller
ALAvram Levy
Avram Levy
YLYi-Horng Ler
Yi-Horng Ler
DWDavid T Williams
David T Williams
Japanese encephalitis virus (JEV) emerged across mainland Australia in 2022, causing substantial impacts on public health and the pig industry. Its emergence raised concerns regarding potential spread into Western Australia (WA). This study aimed to determine JEV activity in WA with a focus on the Kimberley region between 2022 and 2024. It also examined potential pathways of JEV introduction into the state and the challenges associated with flavivirus serology. An integrated surveillance program comprising targeted feral pig surveillance and sentinel chicken monitoring was implemented across northern WA. Sera were screened using flavivirus ELISAs and confirmatory plaque reduction neutralisation tests (PRNT), while feral pig tonsils were tested by RT-qPCR. Evidence of JEV activity was detected in WA between 2022 and 2024. Serological findings from two feral pigs sampled in October 2022 provided the earliest indication of JEV transmission in the Kimberley region. Sentinel chicken surveillance subsequently identified JEV activity in Kununurra, Wyndham, Halls Creek and Newman during 2023 and Derby in 2024. These results provide the first published evidence of JEV activity in WA and highlight the importance of ongoing surveillance, vaccination, mosquito control and preparedness activities in northern Australia.